These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9768758)

  • 21. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of an MHC class II molecule with covalently bound single peptides.
    Fremont DH; Hendrickson WA; Marrack P; Kappler J
    Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conserved structural features between HLA-DO beta and -DR beta.
    Thibodeau J; Lavoie PM; Samaan A; Corre JP; Sékaly RP; Cazenave PA
    Mol Immunol; 1998 Sep; 35(13):885-93. PubMed ID: 9839557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic peptide binding by class I and class II histocompatibility proteins.
    Stern LJ; Wiley DC
    Structure; 1994 Apr; 2(4):245-51. PubMed ID: 8087551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
    Denzin LK; Cresswell P
    Cell; 1995 Jul; 82(1):155-65. PubMed ID: 7606781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly conserved, potential cleavage sites about the desetopes of MHC class I and class II molecules.
    Lam V; Thomas LJ; Kostyal DA; Humphreys RE
    Tissue Antigens; 1992 Jan; 39(1):26-31. PubMed ID: 1542874
    [No Abstract]   [Full Text] [Related]  

  • 28. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
    Zhu Y; Rudensky AY; Corper AL; Teyton L; Wilson IA
    J Mol Biol; 2003 Feb; 326(4):1157-74. PubMed ID: 12589760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DM Stabilizes the Empty MHCII Binding Groove: A Model Using Customized Natural Move Monte Carlo.
    Demharter S; Knapp B; Deane C; Minary P
    J Chem Inf Model; 2019 Jun; 59(6):2894-2899. PubMed ID: 31070900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural network method for predicting peptides that bind major histocompatibility complex molecules.
    Gulukota K; DeLisi C
    Methods Mol Biol; 2001; 156():201-9. PubMed ID: 11068761
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
    van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
    Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.
    van Lith M; van Ham M; Neefjes J
    Eur J Immunol; 2003 May; 33(5):1145-51. PubMed ID: 12731039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical, invariant chain-independent role for H2-M in antigen presentation.
    Swier K; Brown DR; Bird JJ; Martin WD; Van Kaer L; Reiner SL
    J Immunol; 1998 Jan; 160(2):540-4. PubMed ID: 9551884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I.
    Stagsted J
    APMIS Suppl; 1998; 85():1-40. PubMed ID: 9849573
    [No Abstract]   [Full Text] [Related]  

  • 37. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines.
    Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ
    Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of a pheromone receptor-associated MHC molecule with an open and empty groove.
    Olson R; Huey-Tubman KE; Dulac C; Bjorkman PJ
    PLoS Biol; 2005 Aug; 3(8):e257. PubMed ID: 16089503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonclassical MHC class II molecules.
    Alfonso C; Karlsson L
    Annu Rev Immunol; 2000; 18():113-42. PubMed ID: 10837054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.
    Siegrist CA; Martinez-Soria E; Kern I; Mach B
    J Exp Med; 1995 Dec; 182(6):1793-9. PubMed ID: 7500024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.